Skip to main content
. 2019 Apr 9;8(8):746–757. doi: 10.1002/sctm.18-0183

Figure 2.

Figure 2

Cartilage and synovitis composite scores over 12 months. (A): Cartilage morphology does not change after mesenchymal stromal cell (MSC) treatment. Fold change relative to baseline is shown. n = 4 for each MSC dose. (B): Synovitis score (shown as fold change relative to baseline) differs slightly between doses. n = 4 for 50 and n = 3 for 10 and 1 million MSC dose. No significant differences were found between baseline and 1‐year follow‐up.